不同粒径颗粒物短期暴露对慢阻肺患者血压的影响及炎症表型作用
该研究在慢阻肺患者中评估不同粒径颗粒物短期暴露与血压变化的关系,重点关注超细颗粒物与PM2.5、PM10的效应差异。结果显示超细颗粒物暴露与血压升高相关,较小粒径颗粒物更早引起收缩压升高,且中心动脉压变化高于外周血压。嗜酸性粒细胞表型患者更易感,尤其在合并高血压时更明显。
要点
- 超细颗粒物暴露与慢阻肺患者血压升高相关。
- 较小粒径颗粒物更早引起收缩压升高,中心动脉压变化更明显。
- 嗜酸性粒细胞表型患者更易感,合并高血压者风险更高。
核心结论
- 超细颗粒物暴露与慢阻肺患者血压升高相关,较小粒径颗粒物倾向于更早引起收缩压升高,中心动脉压变化高于外周血压。
- 嗜酸性粒细胞表型而非中性粒细胞表型的慢阻肺患者对颗粒物相关血压升高更易感,合并高血压时更明显。
研究设计与样本
- 研究类型、样本量、随访方式及统计方法在原文中未报告。
- 研究对象为慢阻肺患者,比较不同粒径颗粒物暴露与血压变化的关系。
主要发现
- 超细颗粒物暴露与血压升高相关。
- 较小粒径颗粒物倾向于更早引起收缩压升高,表现为中心动脉压变化高于外周测量值。
- 嗜酸性粒细胞表型患者对颗粒物相关血压升高更易感,中性粒细胞表型未显示类似易感性。
- 合并高血压的嗜酸性粒细胞表型患者易感性更明显。
临床怎么用
- 对慢阻肺患者,尤其嗜酸性粒细胞表型及合并高血压者,需关注颗粒物暴露时的血压变化。
- 评估颗粒物健康效应时,中心动脉压可能比外周血压更敏感。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
WHAT IS ALREADY KNOWN ON THIS TOPIC Cardiovascular disease is the most common and most important comorbidity in chronic obstructive pulmonary disease (COPD). Hypertension, the leading risk factor for cardiovascular disease, is present in nearly half of patients with COPD. However, the key environmental risk factors and susceptible phenotypes underlying blood pressure elevation in COPD remain poorly understood. WHAT THIS STUDY ADDS This study provides the first scientific evidence linking exposure to ultrafine particles with increased blood pressure, and directly compares these effects with those of fine particulate matter (PM 2.5 ) and inhalable PM (PM 10 ) in patients with COPD. Smaller particles tended to exhibit earlier elevations in systolic blood pressure, characterised by central pressure changes higher than peripheral measurements. Of note, patients with an eosinophilic, but not neutrophilic, phenotype showed heightened susceptibility, especially when hypertension was present. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR...
引用
- Thorax:Short-term effects of size-fractioned particulate matter on blood pressure in patients with COPD: the key role of inflammatory phenotypes
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。